Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
34553
Description
A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs; ODM derived from: https://clinicaltrials.gov/show/NCT01034397
Link
https://clinicaltrials.gov/show/NCT01034397
Keywords
Versions (2)
- 1/19/19 1/19/19 -
- 5/21/19 5/21/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 19, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Rheumatoid Arthritis NCT01034397
Eligibility Rheumatoid Arthritis NCT01034397
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT01034397
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
adult patients, >/=18 years of age
boolean
ID.2
Item
moderate to severe rheumatoid arthritis of >/=6 months duration
boolean
ID.3
Item
synovitis (swollen and tender joint) in the wrist of the dominant hand
boolean
ID.4
Item
non-biologic dmards at stable dose for >/=12 weeks prior to baseline
boolean
ID.5
Item
oral corticosteroids at stable dose for at least 25 out of 28 days prior to baseline
boolean
ID.6
Item
rheumatic autoimmune disease other than ra
boolean
ID.7
Item
history of or current inflammatory joint disease other than ra
boolean
ID.8
Item
functional class iv (acr classification)
boolean
ID.9
Item
intraarticular or parenteral corticosteroids within 6 weeks prior to baseline
boolean
ID.10
Item
previous treatment with a biologic agent for ra
boolean